BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 29360924)

  • 1. Neopepsee: accurate genome-level prediction of neoantigens by harnessing sequence and amino acid immunogenicity information.
    Kim S; Kim HS; Kim E; Lee MG; Shin EC; Paik S; Kim S
    Ann Oncol; 2018 Apr; 29(4):1030-1036. PubMed ID: 29360924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine learning methods and harmonized datasets improve immunogenic neoantigen prediction.
    Müller M; Huber F; Arnaud M; Kraemer AI; Altimiras ER; Michaux J; Taillandier-Coindard M; Chiffelle J; Murgues B; Gehret T; Auger A; Stevenson BJ; Coukos G; Harari A; Bassani-Sternberg M
    Immunity; 2023 Nov; 56(11):2650-2663.e6. PubMed ID: 37816353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-level distribution and putative immunogenicity of cancer neoepitopes.
    Wood MA; Paralkar M; Paralkar MP; Nguyen A; Struck AJ; Ellrott K; Margolin A; Nellore A; Thompson RF
    BMC Cancer; 2018 Apr; 18(1):414. PubMed ID: 29653567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus-like particle-mediated delivery of structure-selected neoantigens demonstrates immunogenicity and antitumoral activity in mice.
    Barajas A; Amengual-Rigo P; Pons-Grífols A; Ortiz R; Gracia Carmona O; Urrea V; de la Iglesia N; Blanco-Heredia J; Anjos-Souza C; Varela I; Trinité B; Tarrés-Freixas F; Rovirosa C; Lepore R; Vázquez M; de Mattos-Arruda L; Valencia A; Clotet B; Aguilar-Gurrieri C; Guallar V; Carrillo J; Blanco J
    J Transl Med; 2024 Jan; 22(1):14. PubMed ID: 38172991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pTuneos: prioritizing tumor neoantigens from next-generation sequencing data.
    Zhou C; Wei Z; Zhang Z; Zhang B; Zhu C; Chen K; Chuai G; Qu S; Xie L; Gao Y; Liu Q
    Genome Med; 2019 Oct; 11(1):67. PubMed ID: 31666118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole-exome sequencing.
    Karasaki T; Nagayama K; Kuwano H; Nitadori JI; Sato M; Anraku M; Hosoi A; Matsushita H; Takazawa M; Ohara O; Nakajima J; Kakimi K
    Cancer Sci; 2017 Feb; 108(2):170-177. PubMed ID: 27960040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation position is an important determinant for predicting cancer neoantigens.
    Capietto AH; Jhunjhunwala S; Pollock SB; Lupardus P; Wong J; Hänsch L; Cevallos J; Chestnut Y; Fernandez A; Lounsbury N; Nozawa T; Singh M; Fan Z; de la Cruz CC; Phung QT; Taraborrelli L; Haley B; Lill JR; Mellman I; Bourgon R; Delamarre L
    J Exp Med; 2020 Apr; 217(4):. PubMed ID: 31940002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GNIFdb: a neoantigen intrinsic feature database for glioma.
    Li W; Sun T; Li M; He Y; Li L; Wang L; Wang H; Li J; Wen H; Liu Y; Chen Y; Fan Y; Xin B; Zhang J
    Database (Oxford); 2022 Feb; 2022():. PubMed ID: 35150127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoantigen Dissimilarity to the Self-Proteome Predicts Immunogenicity and Response to Immune Checkpoint Blockade.
    Richman LP; Vonderheide RH; Rech AJ
    Cell Syst; 2019 Oct; 9(4):375-382.e4. PubMed ID: 31606370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immunogenic personal neoantigen vaccine for patients with melanoma.
    Ott PA; Hu Z; Keskin DB; Shukla SA; Sun J; Bozym DJ; Zhang W; Luoma A; Giobbie-Hurder A; Peter L; Chen C; Olive O; Carter TA; Li S; Lieb DJ; Eisenhaure T; Gjini E; Stevens J; Lane WJ; Javeri I; Nellaiappan K; Salazar AM; Daley H; Seaman M; Buchbinder EI; Yoon CH; Harden M; Lennon N; Gabriel S; Rodig SJ; Barouch DH; Aster JC; Getz G; Wucherpfennig K; Neuberg D; Ritz J; Lander ES; Fritsch EF; Hacohen N; Wu CJ
    Nature; 2017 Jul; 547(7662):217-221. PubMed ID: 28678778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy.
    Bai P; Li Y; Zhou Q; Xia J; Wei PC; Deng H; Wu M; Chan SK; Kappler JW; Zhou Y; Tran E; Marrack P; Yin L
    Oncoimmunology; 2021 Jan; 10(1):1868130. PubMed ID: 33537173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a novel tumor neoantigen prediction tool for personalized vaccine design.
    Xin K; Wei X; Shao J; Chen F; Liu Q; Liu B
    Hum Vaccin Immunother; 2024 Dec; 20(1):2300881. PubMed ID: 38214336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLimmuno2: predicting MHC class II antigen immunogenicity through transfer learning.
    Wang G; Wu T; Ning W; Diao K; Sun X; Wang J; Wu C; Chen J; Xu D; Liu XS
    Brief Bioinform; 2023 May; 24(3):. PubMed ID: 36960769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TruNeo: an integrated pipeline improves personalized true tumor neoantigen identification.
    Tang Y; Wang Y; Wang J; Li M; Peng L; Wei G; Zhang Y; Li J; Gao Z
    BMC Bioinformatics; 2020 Nov; 21(1):532. PubMed ID: 33208106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neodb: a comprehensive neoantigen database and discovery platform for cancer immunotherapy.
    Wu T; Chen J; Diao K; Wang G; Wang J; Yao H; Liu XS
    Database (Oxford); 2023 Jun; 2023():. PubMed ID: 37311149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DeepAntigen: a novel method for neoantigen prioritization via 3D genome and deep sparse learning.
    Shi Y; Guo Z; Su X; Meng L; Zhang M; Sun J; Wu C; Zheng M; Shang X; Zou X; Cheng W; Yu Y; Cai Y; Zhang C; Cai W; Da LT; He G; Han ZG
    Bioinformatics; 2020 Dec; 36(19):4894-4901. PubMed ID: 32592462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer Neoantigens: Challenges and Future Directions for Prediction, Prioritization, and Validation.
    Borden ES; Buetow KH; Wilson MA; Hastings KT
    Front Oncol; 2022; 12():836821. PubMed ID: 35311072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ProGeo-neo: a customized proteogenomic workflow for neoantigen prediction and selection.
    Li Y; Wang G; Tan X; Ouyang J; Zhang M; Song X; Liu Q; Leng Q; Chen L; Xie L
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):52. PubMed ID: 32241270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying neoantigens for use in immunotherapy.
    Hutchison S; Pritchard AL
    Mamm Genome; 2018 Dec; 29(11-12):714-730. PubMed ID: 30167844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel neoantigen discovery approach based on chromatin high order conformation.
    Shi Y; Zhang M; Meng L; Su X; Shang X; Guo Z; Li Q; Lin M; Zou X; Luo Q; Yu Y; Wu Y; Da L; Cai TW; He G; Han ZG
    BMC Med Genomics; 2020 Aug; 13(Suppl 6):62. PubMed ID: 32854726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.